KYSO KNOCK YOUR SOCKS OFF Trademark
KYSO KNOCK YOUR SOCKS OFF is a USPTO trademark filed by Genmab A/S. Status: Registered.
Trademark Facts
| Mark | KYSO KNOCK YOUR SOCKS OFF |
|---|---|
| Serial Number | 79368784 |
| Registration Number | 7394274 |
| Status | Registered |
| Filing Date | 2023-01-13 |
| Registration Date | 2024-05-28 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Genmab A/S |
| Attorney of Record | Max Vern |
| Prosecution Events | 27 |
| Latest Event | FINO on 2024-11-30 |
Goods & Services
Biological preparations for use in industry and science for in vitro and in vivo scientific and industrial research and development with regard to diseases; Biochemical preparations for in vitro and in vivo scientific research purposes with regard to diseases; biochemical reagents used for non-medical purposes in the nature of in vitro and in vivo scientific and industrial research with regard to diseases; chemicals for use in biotechnological product development in the nature of in vitro and in vivo industrial product development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of cancer, autoimmune diseases, and inflammatory disorders | - Pharmaceutical and veterinary preparations including preparations based on antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof, namely, products for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical and veterinary preparations, including preparations based on antibodies, and bi- and multi- specific antibodies as well as fragments, derivatives and conjugates thereof, for the treatment of cancer, autoimmune diseases, and inflammatory disorders | Medical, scientific and biological research in the fields of antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof and development of pharmaceutical products based on the same; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data for use in medical scientific research, development and therapy and scientific research, development and therapy with antibodies and bi- and multi- specific antibodies as well as fragments, derivatives or conjugates of any of these | Legal services relating to the exploitation of patents and licensing of intellectual property in the field of medicine